Quantcast

Latest Syneron Medical Ltd. Stories

2014-09-15 16:28:28

YOKNEAM, Israel, Sept. 15, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, from 10:00 am to 1:00 pm ET in New York City (registration starts 15 minutes ahead of the meeting at 9:45 am ET ). The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received...

2014-09-15 16:28:06

YOKNEAM, Israel, Sept. 15, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic products and technology, announced today that Allure Magazine has named elure(TM) Advanced Brightening Lotion its "Best Anti-Ager for Discoloration" in its annual Best of Beauty issue, which is published in October every year. This is the fourth consecutive win for elure in Allure Magazine's Best of Beauty issue. elure(TM) has earned this honor each year since...

2014-08-14 08:29:56

Fungus Indication Expands Functionality of Gentle Pro Laser Series IRVINE, Calif., Aug. 14, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today the market launch of its proprietary handpiece featuring a new 5-millimeter spot size for the Gentle Pro Nd:YAG Laser Series. http://photos.prnewswire.com/prnvar/20120528/535447 The introduction of this new FDA-cleared handpiece expands the functionality of the GentleYAG(®...

2014-08-06 08:30:38

Revenue of $64.6 million; non-GAAP EPS $0.07 YOKNEAM, Israel, Aug. 6, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended June 30, 2014. http://photos.prnewswire.com/prnvar/20120528/535447 Second Quarter 2014[1] and Second Quarter 2013 on a Pro-Forma Basis (Excluding Syneron Beauty) and Recent Highlights Include: -- Total revenue of $64.6 million, up 6.1% year-over-year...

2014-07-28 08:30:06

New Device Featured in Upcoming Presentation by Dr. Henry Chan at IMCAS Asia Conference HONG KONG, July 28, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that its new PicoWay® device has received CE Mark indication to treat tattoos of all types and colors and pigmented lesions on any skin type. PicoWay is a new and innovative dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes Syneron's...

2014-07-25 08:26:23

YOKNEAM, Israel, July 25, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014....

2014-07-18 16:23:23

YOKNEAM, Israel, July 18, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release second quarter 2014 financial results before the market opens on Wednesday, August 6, 2014. The earnings release will be available on Syneron's website at www.investors.syneron.com. Syneron management will host a conference call and a live webcast at 8:30 a.m. (ET) on the same day. A question & answer session will...

2014-05-30 08:25:41

YOKNEAM, Israel, May 30, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Shimon Eckhouse, Active Chairman, is scheduled to present at the Jefferies 2014 Global Healthcare Conference in New York, NY. This conference will allow institutional investors to meet with the Company and includes a formal presentation. http://photos.prnewswire.com/prnvar/20120528/535447 Conference: Jefferies 2014...

2014-05-14 08:29:51

Revenue of $56.8 million; non-GAAP EPS $0.04 YOKNEAM, Israel, May 14, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended March 31, 2014. http://photos.prnewswire.com/prnvar/20120528/535447 First Quarter 2014(1) and First Quarter 2013 on a Pro-Forma Basis (Excluding Syneron Beauty) and Recent Highlights Include: -- Total revenue of $56.8 million, up 2.0% year-over-year....

2014-04-28 20:22:52

TOKYO, April 28, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that that its subsidiary in Japan, Candela KK, received registration approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its ALEX II(TM) system in Japan for the treatment of benign dermal lesions. http://photos.prnewswire.com/prnvar/20120528/535447 A special configuration of Candela's successful Alex TriVantage® platform...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related